Spectrum of candidate molecules against Chikungunya virus - an insight into the antiviral screening platforms

Shree Madhu Bhat, Piya Paul Mudgal, N. Sudheesh, Govindakarnavar Arunkumar

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)


Introduction: Chikungunya disease has undergone a phenomenal transition in its status from being recognized as a sporadic infection to acquiring a global prominence over the last couple of decades. The causative agent behind the explosive epidemics worldwide is the re-emerging pathogen, Chikungunya virus (CHIKV). Areas covered: The current review discusses all the possible avenues of antiviral research towards combating CHIKV infection. Aspects of antiviral drug discovery such as antiviral targets, candidate molecules screened, and the various criteria to be a potential inhibitor are all discussed at length. Existing antiviral drug screening tools for CHIKV and their applications are thoroughly described. Clinical trial status of agents with therapeutic potential has been updated with special mention of candidate molecules under patent approval. Databases such as PubMed, Google Scholar, ScienceDirect, Google Patent, and Clinical Trial Registry platforms were referred. Expert opinion: The massive outbreaks of Chikungunya viral disease in the recent past and the serious health concerns imposed thereby, have driven the search for effective therapeutics. The greatest challenge being the non-availability of robust, reproducible, cost-effective and biologically accurate assay models. Nevertheless, there is a need to identify good models mimicking the appropriate microenvironment of an infectious setting.

Original languageEnglish
Pages (from-to)243-264
Number of pages22
JournalExpert Review of Anti-Infective Therapy
Issue number4
Publication statusPublished - 03-04-2019

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases
  • Virology


Dive into the research topics of 'Spectrum of candidate molecules against Chikungunya virus - an insight into the antiviral screening platforms'. Together they form a unique fingerprint.

Cite this